PK
PKU
Community Contributor
Followers0Total number of followers
Comments0Total number of comments
Member Since2019Date joined
No bio added yet
No link added
Biotech longerterm bet
211011 Draupnir noch ein Anteil von rund 55,5% an Polypeptide. Der «Free Float» an der Börse SIX erhöht sich dadurch gleichzeitig von 40,0 auf rund 44,5%.Read more
0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
PK
CHF 33.1
24.6% undervalued intrinsic discount
PKU's Fair Value
Revenue
11.03% p.a.
Profit Margin
13.61%
Future PE
18.34x
Price in 2029
CHF 41.08